Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hypertriglyceridemia]

B Föger1, J R Patsch

  • 1Universitätsklinik für Innere Medizin, Innsbruck.

Wiener Medizinische Wochenschrift (1946)
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Hypertriglyceridemias are diverse lipoprotein disorders requiring individualized treatment. Lifestyle changes are primary, with lipid-lowering drugs used for severe cases to prevent pancreatitis and cardiovascular events.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Hyperglycemia in critically ill].

Wiener klinische Wochenschrift·2023
Same author

[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology].

Der Internist·2014
Same author

LRP1b shows restricted expression in human tissues and binds to several extracellular ligands, including fibrinogen and apoE-carrying lipoproteins.

Atherosclerosis·2011
Same author

The role of apolipoprotein A5 in non-alcoholic fatty liver disease.

Gut·2011
Same author

7 detecting cholesteryl ester transfer protein in plasma.

Methods in molecular medicine·2011
Same author

Plasminogen activator inhibitor 1 and visceral obesity during pronounced weight loss after bariatric surgery.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2010
Same journal

Necrotizing fasciitis of the thigh-a devastating sign of intestinal perforation.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Regenerative therapies in rehabilitation with interfaces with occupational medicine, geriatrics, and oncology: the example of extracorporeal shock wave therapy.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Cerebral toxoplasmosis in patients with peripheral B-cell lymphoma : A case series and a literature review.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Post-pandemic rebound of rotavirus and adenovirus in pediatric gastroenteritis: a 6-year antigen-based surveillance study from Turkey.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Neuroaxis involvement in Chikungunya virus infection: a retrospective case series.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

A complicated case of a spinal Scedosporium apiospermum infection with a favorable outcome-case report.

Wiener medizinische Wochenschrift (1946)·2026
See all related articles

Area of Science:

  • Lipidology
  • Cardiovascular Medicine
  • Metabolic Disorders

Context:

  • Hypertriglyceridemias represent a heterogeneous group of lipoprotein disorders.
  • These disorders are associated with significant clinical sequelae, including pancreatitis and atherosclerosis.
  • Effective management necessitates an individualized approach based on patient-specific factors.

Purpose:

  • To outline the individualized treatment strategies for hypertriglyceridemias.
  • To emphasize the role of behavioral modifications and pharmacotherapy in managing these conditions.
  • To highlight the importance of risk stratification for pancreatitis and cardiovascular endpoints.

Summary:

  • The cornerstone of hypertriglyceridemia management involves behavioral interventions such as diet modification, weight control, exercise, reduced alcohol intake, and smoking cessation.

Related Experiment Videos

  • Lipid-lowering drugs are indicated when triglyceride levels exceed 1000 mg/dl to mitigate pancreatitis risk.
  • Pharmacotherapy is also considered for patients at high risk of atherosclerosis, particularly those with a high total cholesterol to HDL ratio, to reduce cardiovascular events.

    • Impact:

    • Individualized treatment plans can significantly reduce the risk of severe complications like pancreatitis.
    • Effective management of hypertriglyceridemias contributes to the prevention of cardiovascular disease.
    • This approach optimizes patient outcomes by tailoring interventions to specific etiological and clinical profiles.